Many attentions have long been paid to the question about the reason why benz [a]-anthracene (
BA
), a very weak carcinogen, increases its carcinogenic activity to the level of the most potent carcinogenic hydrocarbons, such as benzo [a] pyrene (BP) and 3-methylcholanthrene (3-MC), by the substitution of methyl group(s) for the "L-region" (
7
-and 12-positions) hydrogens,
e
.g.
7
, 12-dimethyl-
BA
(DMBA) has a higher carcinogenic activity than BP, and
7
-methyl-
BA
(
7
-MBA) is as carcinogenic as 3-MC (Cavalieri, 1979; Selkirk, 1980). In addition, 3-MC is also an alkyl-substituted
BA
. The marked increase in carcinogenicity of aromatic hydrocarbons by a methyl substituent is observed not only with
BA
but also with other aromatic hydrocarbons, such as chrysene and anthrabene (Cavalieri, 1979; Selkirk, 1980).
5
-Methylchrysene, for instance, has as highly carcinogenic activity as 3-MC whereas carcinogenicity of chrysese is very weak. Similarly,
9
, 10-dimethylanthracene is carcinogenic whereas the mother compound; anthracene, is not carcinogenic (Fig. 1). Several attempts have been made to know active metabolites of DMBA in relation to epoxide formation. DMBA
5
,
6
-oxide has been isolated and identified as an active metabolite from a hepatic mitrosomal reaction mixture (Keysell et al., 1973). DMBA 3,
4
-diol-1, 2-epokide was also strongly assumed to be an active metabolite, but has not been detected yet from the in vitro system (Jerina et al., 1978 ; Malaveille et al., 1978 ; Wislocki bt al:, 1980). These studies, however, were carried out by using liver microsomes from rats pretreated with the P-448 inducer, 3-MC or polychlorinated biphenyls.
8
,
9
- and 10, 11-epoxides of DMBA might also be candidates for the active metabolites since their hydrolysis products,
8
,
9
- and 10, 11-dihydrodiols, have been isolated from a rat liver microsomal system (DiGiovanni and Juchau, 1980).
抄録全体を表示